Literature DB >> 18818896

[Qualitative and quantitative analysis of urolithiasis with the Rietveld method (x-ray diffraction)].

H Euler1, H P Bastian, P J Bastian, G Lümmen.   

Abstract

BACKGROUND: The Rietveld method is one of the most innovative and most important applications in x-ray diffraction and has now, for the first time, been applied to standard-free precise quantitative crystallographic analysis of urinary stones.
MATERIAL AND METHODS: The capability of the Rietveld method was demonstrated by analysis of a synthetic mixture of five typical urinary stones: whewellite, hydroxylapatite, brushite, struvite, and uric acid, with 20 weight % for each pure component.
RESULTS: The quantitative phase analysis (Rietveld method) yielded a mean absolute error of only 1.6% for the weight fractions of the single urinary stone components. The largest error in weight fraction, 2.3%, occurred with hydroxylapatite, caused by the typical insufficient crystallinity.
CONCLUSION: Crystallographic analysis of complex urinary stones with the aid of x-ray diffraction, in combination with a Rietveld structure refinement, is the method of first choice for qualitative and quantitative phase analysis. With this tool, significant changes in weight fractions for recurrent urinary stones can be precisely detected, with therapeutic consequences.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18818896     DOI: 10.1007/s00120-008-1809-z

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  3 in total

1.  Study on the prevalence and incidence of urolithiasis in Germany comparing the years 1979 vs. 2000.

Authors:  A Hesse; E Brändle; D Wilbert; K-U Köhrmann; P Alken
Journal:  Eur Urol       Date:  2003-12       Impact factor: 20.096

Review 2.  Diagnosis and metaphylaxis of stone disease. Consensus concept of the National Working Committee on Stone Disease for the upcoming German Urolithiasis Guideline.

Authors:  M Straub; W L Strohmaier; W Berg; B Beck; B Hoppe; N Laube; S Lahme; M Schmidt; A Hesse; K U Koehrmann
Journal:  World J Urol       Date:  2005-11-29       Impact factor: 4.226

3.  [What kind of stone prevention for whom? Risk-adjusted metaphylaxis following urinary stone disease].

Authors:  M Straub
Journal:  Urologe A       Date:  2006-11       Impact factor: 0.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.